Nektar Therapeutics (NKTR) Tops Q1 EPS by 9c
Tweet
Share
E-mailGet Alerts NKTR Hot Sheet
Price: $73.02 -3.82%
Financial Fact:
Total non-operating expense: -10.18M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total non-operating expense: -10.18M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q1 EPS of ($0.14), $0.09 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $58.9 million versus the consensus estimate of $43.78 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
